GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Lunit Inc (XKRX:328130) » Definitions » Other Income (Expense)

Lunit (XKRX:328130) Other Income (Expense) : ₩21,693 Mil (TTM As of Mar. 2025)


View and export this data going back to 2022. Start your Free Trial

What is Lunit Other Income (Expense)?

Lunit's other income expense for the Lunit's pretax income for the three months ended in Mar. 2025 was ₩27,860 Mil. Its other income expense for the trailing twelve months (TTM) ended in Mar. 2025 was ₩21,693 Mil.

Lunit Other Income (Expense) Historical Data

The historical data trend for Lunit's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lunit Other Income (Expense) Chart

Lunit Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Income (Expense)
Get a 7-Day Free Trial -59,711.78 -25,789.67 -231.45 4,740.45 -5,441.47

Lunit Quarterly Data
Dec18 Dec19 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Other Income (Expense) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 725.54 35,836.20 8,678.14 -50,681.35 27,860.29

Lunit Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩21,693 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lunit  (XKRX:328130) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.

Lunit Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Lunit Inc (XKRX:328130) » Definitions » Other Income (Expense)
Comparable Companies
XKRX:347700 XKRX:338220 XKRX:032620 XKRX:071200 XKRX:315640 XKRX:099750 XKRX:226330 XKRX:032850 XKRX:263700 XKRX:359090 VEEV GEHC ASX:PME TEM DOCS TSE:2413 HQY WAY BTSG HKSE:02587
Traded in Other Exchanges
N/A
Address
374 Gangnam-daero, 4th to 9th Floors, Case Square Gangnam II, Yeoksam-dong, Gangnam-gu, Seoul, KOR, 06241
Website
https://www.lunit.io
Lunit Inc is a medical AI software company devoted to providing AI-powered total cancer care. Its products comprise of Lunit INSIGHT CXR, AI solution for Chest x-ray; Lunit INSIGHT MMG, AI solution for Mammography; Lunit SCOPE IO, AI-Powered Biomarker for Immuno-Oncology; and Lunit SCOPE PD-L1, AI Solution for PD-L1 Expression.

Lunit Headlines

No Headlines